| LF | p | OR | OR 95% CI |
---|
|
---|
| Yes (n=146) | No (n=1286) | | | |
---|
|
---|
| Mean (Sd) | n (%) | Mean (Sd) | n (%) | | | |
---|
|
---|
anti-Ro/SS-A 60 kDa | 39 | 26.7 | 307 | 23.9 | 0.47 | 1.16 | 0.78–1.71 |
anti-Ro52/TRIM21 | 36 | 24.7 | 205 | 15.9 | 0.01 | 1.72 | 1.15–2.58 |
anti-La | 9 | 6.2 | 129 | 10.1 | 0.14 | 0.58 | 0.29–1.17 |
SLE | 25 | 17.1 | 398 | 30.9 | <0.001 | 0.46 | 0.29–0.72 |
MCTD | 13 | 8.9 | 71 | 5.5 | 0.13 | 1.67 | 0.90–3.10 |
OCTD | 13 | 8.9 | 52 | 4.0 | 0.01 | 2.32 | 1.23–4.37 |
SSc | 52 | 35.6 | 107 | 8.3 | <0.001 | 6.09 | 4.11–9.02 |
PM | 26 | 17.8 | 126 | 9.8 | 0.006 | 1.99 | 1.25–3.16 |
SSc-PM | 8 | 5.5 | 16 | 1.2 | 0.002 | 4.60 | 1.93–10.9 |
PSS | 8 | 5.5 | 100 | 7.8 | 0.408 | 0.68 | 0.32–1.44 |
Female | 30 | 20.5 | 229 | 17.8 | 0.42 | 1.19 | 0.78–1.82 |
Age (y.) | 65.25 | 14.5 | 58.3 | 17.2 | <0.001 | 1.02 | 1.01–1.03 |